Michael Morrissey Exelixis, Inc. (EXEL) insider trading activity

Michael Morrissey is President and CEO of EXELIXIS, INC.. Currently has a direct ownership of 1.62 Million shares of EXEL, which is worth approximately $59.9 Million. The most recent transaction as insider was on Mar 31, 2025, when has been sold 589,719 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.62M

120.23% 3M change

56.31% 12M change

Total Value Held $59.9 Million

MICHAEL MORRISSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 31 2025	BUY Grant, award, or other acquisition	-	589,719 Added 26.65%	1,623,009 Common Stock
Feb 26 2025	BUY Grant, award, or other acquisition	-	184,909 Added 15.18%	1,033,290 Common Stock
Feb 24 2025	SELL Bona fide gift	-	177,985 Reduced 17.34%	848,381 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$2,224,950 $35.0 p/Share	63,570 Reduced 5.83%	1,026,366 Common Stock
Jan 16 2025	SELL Payment of exercise price or tax liability	$4,481,493 $37.27 p/Share	120,244 Reduced 9.94%	1,089,936 Common Stock
Jan 16 2025	BUY Grant, award, or other acquisition	-	473,226 Added 28.11%	1,210,180 Common Stock
Dec 20 2024	SELL Bona fide gift	-	179,788 Reduced 19.61%	736,954 Common Stock
Nov 15 2024	SELL Payment of exercise price or tax liability	$1,669,852 $35.05 p/Share	47,642 Reduced 4.94%	916,742 Common Stock
Oct 03 2024	SELL Bona fide gift	-	16,298 Reduced 1.66%	964,384 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$12,195,362 $26.3 p/Share	463,702 Reduced 32.1%	980,682 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$11,716,800 $24.41 p/Share	480,000 Added 24.94%	1,444,384 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$1,552,063 $20.99 p/Share	73,943 Reduced 7.12%	964,384 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	241,670 Added 18.88%	1,038,327 Common Stock
Jan 11 2024	SELL Payment of exercise price or tax liability	$1,456,570 $22.86 p/Share	63,717 Reduced 7.41%	796,657 Common Stock
Jan 11 2024	BUY Grant, award, or other acquisition	-	250,374 Added 22.54%	860,374 Common Stock
Nov 07 2023	SELL Bona fide gift	-	116,893 Reduced 16.08%	610,000 Common Stock
Sep 06 2023	SELL Payment of exercise price or tax liability	$1,037,960 $22.27 p/Share	46,608 Reduced 6.03%	726,893 Common Stock
Sep 06 2023	BUY Grant, award, or other acquisition	-	188,005 Added 19.55%	773,501 Common Stock
Aug 31 2023	SELL Bona fide gift	-	56,221 Reduced 8.76%	585,496 Common Stock
Aug 28 2023	SELL Payment of exercise price or tax liability	$6,737,818 $22.18 p/Share	303,779 Reduced 32.13%	641,717 Common Stock
Aug 28 2023	BUY Exercise of conversion of derivative security	$5,511,600 $15.31 p/Share	360,000 Added 27.58%	945,496 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$501,269 $21.51 p/Share	23,304 Reduced 3.83%	585,496 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$642,875 $19.18 p/Share	33,518 Reduced 5.22%	608,800 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	313,185 Added 32.78%	642,318 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$208,317 $18.08 p/Share	11,522 Reduced 3.38%	329,133 Common Stock

Also insider at

VERA

Vera Therapeutics, Inc. Healthcare

Michael Morrissey

President and CEO

Alameda, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL

Account